Preterm placenta may be more susceptible to maternal infection-induced placental cytokine response resulting in fetal inflammation, new research reveals.
The preterm placenta may be more susceptible to maternal infection-induced placental cytokine response resulting in fetal inflammation, reported researchers from UCLA Medical Center.
Julie Boles, MD, and colleagues used pregnant rats to determine that at day 16 of a 21-day term, placental explants exposed to 1 g/mL lipopolysaccharide (LPS) for 6 hours demonstrated a significant increase in IL-6 (5,072±624 vs 2,062±587 pg/mL/g tissue; P<.01), with a further increase after 12 hours (9,290±467 vs 2,313±268 pg/mL/g tissue; P<.01) compared with unexposed placentas.
In addition, the IL-6 cytokine response to 12-hour exposure to 1 g/mL LPS in 16-day placental explants was twice as high as that in 18-day placental explants.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More